background Resistance to antimonials is a fundamental determinant of treatment failure in anthroponotic cutaneous leishmaniasis (ACL). Detection of reliable molecular markers to distinguish unresponsive and responsive parasites is critical for consolidating strategies to monitor drug efficacy.
Introduction
Leishmaniasis is an arthropod-transmitted protozoan disease caused by different species of the genus Leishmania, which display a wide variety of clinical presentations ranging from a self-healing skin lesion to a fatal visceral form if left untreated. Leishmaniasis is reported from 101 countries/territories and the global estimated incidence of cutaneous leishmaniasis (CL), as a neglected tropical disease, is about 0.7-1.2 million new cases each year [1] . New estimates indicate that the number of cases has drastically increased by a factor of 6 to 10 due to the recent conflicts, particularly in Middle Eastern countries, sustained epidemics and ecological changes [2] [3] [4] .
In Iran, CL is endemic in 18 of 31 provinces [5] with over 20 000 registered cases reported in 2014 [4] , although the actual number might be 2-5 times higher. Leishmania tropica and Leishmania major are the two principal causative agents of anthroponotic (ACL) and zoonotic cutaneous leishmaniasis (ZCL) in the Old World [6] . In Iran, CL treatment is challenging due to resistance to pentavalent antimony compounds (SbV) including meglumine antimonite (MA, Glucantime â ), the first-line treatment against almost all forms of leishmaniasis [7] . The increase of SbV-resistant parasites in ACL induced by L. tropica may be due to lowered susceptibility to SbV, insufficient treatment duration, low dosage uptake and the nature of the anthroponotic transmission cycle (person to person), which is the only measure to control the disease. Iran is among the 10 countries with the highest estimated case counts [1] . Kerman province in the southeast is well known as the main endemic focus of ACL, where >97% of autochthonous cases are caused by L. tropica [8] . Various risk-associated factors [9] have been identified that play a central role in generation of unresponsive isolates. 10.8%, 11% and 11.3% of patients with ACL were unresponsive to treatment with Glucantime in Mashhad [7] , Bam [10] and Kerman counties [11] , respectively. The mechanism of action of SbV remains unclear. It is known that SbV, as a prodrug, needs to be reduced to its trivalent form (SbIII) for activity, which can occur at amastigote stage and in harbouring host macrophages [12, 13] . It is clear that the drug resistance phenotype is multifactorial with one or more simultaneous pathways. Aquaglyceroporin 1 (AQP1) is a membrane transporter which uptakes SbIII, and gene deletion or lower expression of AQP1 renders the parasites resistant [14, 15] . The elevated level of multidrug resistance protein A (MRPA) as an ATP-binding cassette (ABC) transporter has been shown to influence the efflux of drugs by sequestering thiol-metal complexes in intracellular vesicles [16] . Increasing expression of thiol biosynthetic enzymes [c-glutamylcysteine synthetase (c-GCS) and trypanothione reductase (TR)] and decreased levels of SbV enzymatic reduction by thiol-dependent reductase 1 (TDR1) are also involved in resistance [17] [18] [19] . Lower expression of AQP1 gene in most species was observed in resistant than sensitive isolates but expression of MRPA and c-GCS genes was up-regulated in resistant isolates [20, 21] . In recent years, several approaches have been proposed on antimony resistance markers that revealed different genetic and biological behaviour of field isolates relative to the in vitro-induced resistant parasites [21] .
Considering that antimony resistance is a major concern in endemic regions, and that few studies have been performed on L. tropica, the identification of the molecular markers for monitoring the drug-resistant isolates is crucial. The objective of this study was to assess the expression of AQP1, c-GCS, MRPA, TDR1 and TR as resistance genes in clinical antimony-unresponsive and responsive L. tropica isolates obtained from patients with ACL for exploring the potential of targeted expression profiling as a surveillance tool for monitoring the SbV unresponsiveness in field isolates.
Material and methods

Ethical statement
Ethical approval was granted by the Ethical Committee of Kerman University of Medical Sciences (protocol no: 95822933 and ethics no: IR.KMU.REC.1395.242). Written informed consent of the patients was also obtained. Unresponsive patients were referred to the Educational University Hospitals for further checkup and laboratory examinations for combination treatment. Demographic data were kept confidential.
Study area
Since 2005, two clinics in the southeastern province of Kerman, one in Bam and the other in Kerman district, have been acting as referral centres for the management of patients with CL. This comprises clinical examination, passive and active case detection, diagnosis and consequently treatment of CL with meglumine antimoniate alone or in combination. Both clinics are well equipped and teams of well-trained health officers and experienced physicians deliver services to patients free of charge. The national CL protocol in line with the WHO guidelines was initially implemented in these clinics just after the devastating earthquake and sustained CL epidemic in Bam [22] .
Clinical isolates
Clinical isolates were randomly obtained from ACL patients referred to these health centres between January 2016 and February 2017. Samples were collected from 28 patients; 14 unresponsive and 14 responsive to Glucantime â treatment (Sanofi-Aventis, Paris, France). Samples from both groups underwent positive direct microscopic examination.
Unresponsive and responsive cases
Unresponsive cases were defined as patients who presented active lesions despite receiving two courses of Glucantime â either systemically alone (20 mg/kg/day_for 3 weeks) or intralesionally by administration of Glucantime â once a week for 12 weeks coupled with cryotherapy by liquid nitrogen. Patients who were cured after one course of Glucantime â , alone or in combination with cryotherapy as mentioned above, with complete re-epithelialisation of lesion and no relapse after 6 months of the follow-up examinations, were considered as responsive cases.
Sampling and parasite culture
Skin samples were taken from the margin of the lesion using a scalpel and blade (no. 15) and transferred into NNN medium for isolation. Then the isolates were subcultured in RPMI-1640 medium (Biosera, France) supplemented with 10% heat-inactivated (56°C for 30 min) foetal bovine serum (Gibco, Germany), penicillin (100 IU/ml), streptomycin (100 lg/ml) and incubated at 25 AE 1°C in 25 cm 2 culture flasks. L. tropica strain MHOM/IR/10/175 (S175) and MHOM/IR/10/439 (R439)(7), which were used as antimony-sensitive and resistant reference strains, respectively, were recovered from liquid nitrogen and sub-cultured in complete RPMI-1640 medium. Harvested promastigotes were centrifuged (800 9 g for 10 min at room temperature), washed with RPMI-1640 and pellets stored at À70°C for further molecular experiments.
Identification of Leishmania isolates
Genomic DNA of all cultured samples was extracted using the QIAamp DNA Mini Kit (Qiagen, Germany) according to the manufacturer's instructions. Molecular detection of Leishmania isolates was performed by nested PCR, which is able to amplify a variable region of the kinetoplast mini circle DNA (kDNA) for identification of Leishmania species. Nested PCR was carried out in two consecutive steps as described elsewhere [23] .
In brief, two general primers of CSB2XF (CGAGTAG-CAGAAACTCCCGTTCA) and CSB1XR (ATTTTTCGC-GATTTTCGCAGAACG) were used as external primers, then in the second round, 13Z (ACTGGGGGTTGGTG-TAA AATAG) and LiR (TCGCAGAACGCCCCT) were used as specific internal primers. The final PCR products were separated on 1.5% agarose gel electrophoresis and visualised under UV Transilluminator (Uvitech, Cambridge, UK).
PCR and sequencing of resistance genes
Due to the incomplete genome database of L. tropica in GeneBank, initially complete sequences of the AQP1, c-GCS, MRPA, TDR1 and TR genes in L. major, Leishmania donovani and Leishmania infantum strain Friedlin were aligned; afterwards, all conserved DNA sequences extracted by BioEdite software to find the best primers. Finally, PCR amplification of these fragments from genomic DNA was performed with specific primers (Table 1) .
We used L. tropica isolates from unresponsive and responsive patients for PCR amplification and sequencing of these five genes. PCR reactions consisted of 2 ll DNA template, 2.5 ll 109 PCR buffer, 1.5 mM MgCl 2 , 200 lM dNTP, 2 U/ll Taq DNA polymerase (Fermentas, Thermo Scientific, USA), and 10 lM of both primers in a final volume of 25 ll. The amplification was carried out in a FlexCycler (Analytik Jena, Germany) with initial denaturation at 95°C for 5 min, followed by 35 cycles of 95°C for 1 min, of 60°C for 15 s and of 72°C for 20 s, and final extension at 72°C for 5 min. PCR products were analysed by electrophoresis on 1.5% agarose gel. The amplified fragments were excised from the gel and purified using a Gel Extraction Kit (Bioneer, Korea) according to the manufacturer's instructions and sequenced by Macrogen (South Korea). The analysis was performed using the BLAST tool for nucleic acid pairwise sequence alignment and ClustalW programs for multiple sequence alignments as implemented in BioEdit software, version 7.2.5 [24] . Finally, all sequences were aligned and compared to GenBank Refseq isolates to determine the maximum homology.
RNA isolation and cDNA synthesis
Total RNA was extracted from the early stationaryphase promastigotes (5 9 10 7 /ml) of 28 unresponsive and responsive isolates using the High Pure RNA isolation kit (Roche-Mannheim, Germany) following manufacturer's instructions. DNase1 (Roche-Mannheim, Germany) was used for removal of any contaminating DNA. Nanodrop (ND-2000, Thermo Scientific Fisher, USA) and 2% agarose gel electrophoresis were applied for analysing the quantity and quality of RNA samples, respectively. Complementary DNA (cDNA) synthesis was performed using the Prime Script RT reagent Kit (Takara, Tokyo, Japan) according to protocol. Briefly, cDNA was synthesised using 100 ng of extracted RNA, 50 pmol/ll random hexamer primer, 25 pmol/ll oligodT, RT Enzyme Mix I (each in 0.5 ll) and 2 ll of 59 Prime Script Buffer and then incubated at 37°C for 15 min followed by incubation at 85°C for 5 sec to inactivate reverse transcriptase. The obtained cDNA was diluted in DNase/RNase-free distilled water and stored at À70°C until use.
Real-time qPCR analysis
Real-time qPCR was carried out to confirm the differences in expression level of five resistance markers among the unresponsive and responsive L. tropica isolates. Based on the sequences obtained from PCR amplification of genomic DNA from the subject genes of L. tropica, real-time qPCR primers were designed by Primer 3 software version 0.4.0 (http://frodo.wi.mit.edu/ ). The efficiency of each primer was assessed by serial dilutions of pooled cDNA on real-time qPCR. 40S ribosomal protein (40S) primer was used as the housekeeping gene for normalisation purpose. The sequences of each gene amplified in this study are given in Table 2 . Quantitative PCR was performed by SYBR â Premix Ex Taq TM II (Takara, Japan) on a real-time PCR cycler, Rotor-Gene 6000 (Corbett, Qiagen). Each reaction had a total volume of 15 ll, containing 2 ll of cDNA target, 7 ll SYBR â Premix, and primers at a final concentration of 50 nM. PCR amplification was run thrice by the thermal profile of initial denaturation at 95°C for 30 s followed by 40 cycles, each consisting of denaturation at 94°C for 10 s, annealing at 60°C for 18 s and extension at 72°C for 20 s. The specificity of reaction was determined by a melt curve analysis. Agarose gel analysis of amplified product was also performed to indicate a single and specific band. A no-cDNA sample was included as a negative control in each run for each gene.
Analysis of gene expression
To calculate the relative value of the expression, the 2
ÀDDCt method was used as a relative quantification strategy for qPCR data analysis [25] . The relative expression of resistance genes in L. tropica field isolates was determined based on the cycle threshold (Ct) value of the target gene with that of the reference gene, 40S ribosomal protein, to normalise the results and relative to the resistant and sensitive reference isolates. Differential expression of a clinical sample compared to the sensitive reference isolate of S175 was expressed as the fold change.
Statistical analysis
Data were analysed using independent sample t-test. Also, Pearson's rank correlation coefficients were used. P values for significant differences in the expression levels of unresponsive and responsive parasites of different genes were calculated with GraphPad Prism 7.01 (GraphPad Software, Inc., San Diego, CA, USA). The results are presented as the mean AE standard deviations (SDs). A P < 0.05 was considered to be statistically significant.
Results
Clinical data
A total of 28 unresponsive and responsive patients with confirmed lesions of ACL, who lived in CL-endemic regions of Kerman Province, in Southeast of Iran, were recruited (Table 3 , Figure 1 ). Diagnosis and confirmation of L. tropica were based on positive direct smear preparations from skin lesions, culture of promastigotes in NNN isolation medium and nested-PCR. The entire field isolates and both reference strains displayed the specific band of 750 bp with nested-PCR; L. tropica was the only 
species identified as the causative agent in all our CL patients ( Figure 2 ). Of 14 unresponsive patients, five were female and nine were male, with a mean AE SD age of 18.5 AE 15 years (range 6-53 years). Seven females and seven males with a mean AE SD age of 23.5 AE 11.5 years comprised the responsive group. Ulcerated and nodular lesions were the most prevalent clinical forms in both groups (57% and 64%, respectively). In unresponsive patients, nine lesions were observed on the face (cheek and around lips, 47.3%); eight on the arms, hands and fingers (42%); one on the ear and one on the leg. In responsive patients, the lesions were mostly on the hands and arms (76.5%). The mean AE SD size of unresponsive and responsive lesions was 2.5 AE 1.1 and Figure 1 Representative pictures of skin lesions taken from anthroponotic cutaneous leishmaniasis cases due to Leishmania tropica in areas of Kerman Province, southeastern Iran. (a-e) unresponsive patients; (f-j) responsive patients.
1.6 AE 0.7 cm, which ranged from 0.5 to 4 and 0.4 to 1.5 cm, respectively (Table 3) .
Resistance genes PCR amplification and sequencing
Fragments of AQP1, c-GCS, MRPA, TDR1 and TR resistance markers were designed and amplified using specific primers. Figure 3 shows bands of 945 bp for AQP1, 753 bp for MRPA, 780 bp for c-GCS, 688 for TDR1 and 1076 bp for TR obtained from unresponsive and responsive isolates. Sample PCR products of resistance markers were subjected to sequencing and the resulting sequences were deposited in the NCBI database.
Alignment and phylogenetic analysis of nucleotide sequences
Nucleotide sequences of these resistance genes were deposited in the GenBank database under accession numbers MG603679-MG603680 and MG797691-MG797696. Due to the lack of corresponding genomic sequence information for L. tropica in any of these genetic regions in Nucleotide Database, the identity of each sequence was compared with Reference sequences of other Leishmania species. BLAST results have demonstrated maximum identity (please rephrase: either it is identical or very similar) with L. major in the range of 93-99% for nucleotide sequences and 87-99% for amino aside sequences.
cDNA synthesis
The conventional PCR was carried out using resistance markers and 40S primer (as the reference gene), to evaluate the integrity of synthesised cDNA and to ascertain the desired band. The amplified products exhibited the resistance genes of AQP1 (143 bp), MRPA (102 bp), TR (103 bp), c-GCS (90 bp), TDR1 (137 bp) and also 40S (71 bp) as the internal control gene (Figure 4 ).
Gene expression analysis of L. tropica clinical isolates
Gene expression levels of 5 target genes in 28 L. tropica clinical isolates (14 unresponsive and 14 responsive) with respect to S175 and R439 reference isolates were verified by real-time qPCR. Based on our results, AQP1 was down-regulated in 9 of 14 unresponsive isolates, and upregulated in all responsive isolates except one, from 1.4-fold to 7.4-fold (P = 0.04). The expression of c-GCS was increased in all responsive isolates except one. In unresponsive isolates, the gene expression was decreased in six of 14 and showed normal expression comparable to R439 in four isolates; increased expression was also observed in four isolates (P = 0.007). MRPA was upregulated in all unresponsive isolates from 1.5-fold to 25.2-fold; although it exhibited the elevated expression level in 12 responsive isolates (P > 0.05). TR expression level was decreased in all but three isolates in both groups of patients and no difference was found. High expression of TDR1 was observed in 12 of 14 responsive isolates from 2.3-fold to 1124-fold; whereas in unresponsive isolates, it displayed high expression in only four isolates, although no significant difference was observed ( Figure 5 ). Figure 6 shows the up-regulation of AQP1 1.9-fold and c-GCS by a factor of 1.7 in responsive isolates vs. unresponsive ones (P < 0.05) and by a factor of 3.55 for TDR-1 (P > 0.05). Furthermore, 1.9-fold MRPA up-regulation was observed in unresponsive isolates and suppression level was shown for TR in both groups (P > 0.05). The incidence of expression in AQP1 and c-GCS genes was greater in responsive than unresponsive isolates (92 vs. 43).
Significant differences were observed in the mean expression level AE SD in unresponsive vs. responsive parasites for AQP1 (1.65 AE 1.88 vs. 3.09 AE 2.08; P = 0.04) and c-GCS (1.20 AE 0.66 vs. 2.02 AE 0.8; P = 0.007), while expression levels of the three other genes did not significantly differ between the two groups: MRPA (5.84 AE 6.81 vs. 3.17 AE 1.63; P = 0.16); TDR1 (62.38 AE 118.2 vs. 221.6 AE 378.8; P = 0.14); TR (0.96 AE 1.15 vs. 0.88 AE 0.27; P = 0.79) (Figure 6 ).
Correlation analysis of expression levels between resistance markers
A strong positive linear correlation between gene expression of AQP1 and c-GCS was observed in isolates (r = 0.65, P = 0.0001) and it was revealed that when AQP1 was up-regulated by parasites, c-GCS expression simultaneously increased (Figure 7) . Furthermore, the correlation between c-GCS and TDR1 genes was nearly significant (r = 0.35, P = 0.06).
Correlation between resistance gene expression level and lesions in cutaneous leishmaniasis patients
Our study revealed a negative statistical correlation between the c-GCS expression level and lesion duration in responsive patients, indicating that its expression increases with the decrease in the duration of lesions in responsive isolates (r = À0.57, P = 0.03) (Figure 8a ). AQP1 significantly correlated with negative values (r = À0.40, P = 0.01) (Figure 8b ). However, it showed no linear correlation between other genes expression levels and lesion duration in patients (Figure 8c ).
Discussion
In recent decades, the emergence of drug resistance in leishmaniasis is one of the main barriers for the effective treatment in clinical isolates. Studies on antimony resistance have indicated the existence of various mechanisms involved in both parasite and host macrophages [16, 26] . Identification of proper resistance markers for detecting and monitoring resistance in patients with ACL could be helpful for designing new strategies to preserve the efficacy of currently used drugs. Resistance mechanisms differ between field and laboratory isolates [21] . In our study, ulcerated and nodular lesions were more common in unresponsive and responsive patients with the lesions on the face and hands as the most common sites of involvement, respectively. This is consistent with those reported by Khosravi et al., which demonstrated that papules and hands were the most common form and site in ACL patients [27] . Few studies have been performed on field isolates of Leishmania resistance to antimonials, especially by L. tropica. In Mashhad city, 10.8% of patients with ACL were non-responsive to Glucantime treatment in the macrophage cultivation model; although no difference was observed between L. tropica-sensitive and resistant strains based on sequencing of the pteridine reductase 1 gene [7] . In another study, the differential expression of the activated protein kinase C receptor (LACK), as a gene involved in important cellular activities such as signalling pathway, was investigated in resistant and sensitive clinical L. tropica isolates using realtime RT-PCR. Its expression level was up-regulated in most sensitive isolates, but it was not significantly reduced in resistant ones [28] . In the present study, the expression pattern of five major resistance genes including AQP1, MRPA, c-GCS, TDR1 and TR in different clinical isolates was assessed using real-time qPCR. Our sequence alignment analysis shows that all sequences exhibit great similarity to the L. major sequences in the Refseq database. Aquaglyceroporin 1 (AQP1) has been identified as a membrane channel, which mediates SbIII uptake in Leishmania and modulates drug sensitivity. Its role in osmotaxis and transporting water, solute and toxic compounds such as methylglyoxal, arsenite and antimonite has been indicated [29] . Transfection of AQP1 could be able to render SbVresistant isolates hypersensitive by increasing the accumulation of Sb(III) [14, 30] . Our findings showed a significant decrease in expression level of AQP1 in nine unresponsive isolates by 1.9-fold, whilst its expression was up-regulated in all responsive isolates. A recent study from India reported a significant down-regulation of RNA transcripts of AQP1 in antimony-resistant clinical isolates. The decrease was more significant in isolates with higher resistance indices [31] . Similar results were observed in other studies of different Leishmania species [20, 21, 32] . Genetic variations such as mutations and/or gene polymorphisms may influence AQP1 expression. A number of deletion and point mutations in AQP1 have been indicated in antimony-resistant Leishmania parasites [33] . Some therapeutic elements, including silver and nitrate salts, also influence AQP1 activity [34] .
c-Glutamylcysteine synthetase (c-GCS) is a key enzyme for glutathione (GSH) biosynthesis. Trypanothione (TSH), a conjugate of GSH and spermidine, is one of the major thiols involved in the maintenance of the intracellular reducing environment in Leishmania parasites for survival [30] . Overexpression of c-GCS has been The values are the mean AE SD of three independent experiments (**P < 0.01 and *P < .05).
described in both experimental and clinical isolates of antimony-resistant Leishmania [14, 21, 35] . Our findings were inconsistent with above-mentioned studies that demonstrated up-regulation of c-GCS in all responsive isolates and only in four unresponsive ones. However, results in clinical isolates were variable. Neither amplification nor up-regulation of c-GCS expression level was observed in L. donovani from Indian resistant isolates [36, 37] . Also, expression of c-GCS was significantly decreased in resistant isolates from Nepal [38, 39] . Expression of c-GCS was not increased through TSH overproduction in the antimony-resistant vs. susceptible cell line [40] . Some studies have indicated lower expression of c-GCS in macrophages, probably by down-regulating host NF-jB, which is responsible for c-GCS expression regulation [41] . Also, its expression as a marker of drug sensitivity in myeloid leukaemia patients showed an increased mRNA levels after treatment [42] . The results presented here display an inverse association between the c-GCS and AQP1 gene expression with lesion duration, and indicate that lower expression of c-GCS and AQP1 genes may enhance parasite persistence, which in turn induces more inflammatory reactions. Our results also demonstrate a powerful positive correlation between AQP1 and c-GCS gene expression, indicating that the expression of AQP1 and c-GCS genes may directly/indirectly influence the expression of each other.
Multidrug resistance protein A (MRPA), as an ABC transporter, confers resistance by decreasing influx of antimony through sequestration of thiol-metal conjugates [16, 43] . Overexpression of MRPA in laboratory mutants and natural antimony resistance isolates has been associated with resistance in several studies, notably in L. donovani field isolates from India [16, 20, 37, 44] . In contrast, no gene amplification was observed in L. donovani from Nepal or in L. braziliensis and L. guyanensis from the New World species [45, 46] . In our results, the average value in unresponsive isolates showed a 1.9-fold MRPA expression; however, it was not significant between the two groups. These differences may be attributed to the diversity in resistance indices between Leishmania species or strains that is influenced by the genetic background of the parasite. It has been indicated that increased MRPA expression in L. amazonensis is associated with the extrachromosomal amplicons formation or the increased ploidy of the relevant chromosome [44] . The occurrence of the similar phenomenon in our investigated L. tropica isolates need to be clarified in future studies. Trypanothione reductase (TR) is a flavoenzyme that catalyses the reduction of trypanothione disulfide (TS 2 ) to TSH. Overexpressed level of TR can cause the increased levels of TSH, which is required for thiol-metal conjugates and to overcome the inhibitory effect of SbIII [40] . An increased level of TR has been observed in antimony-resistant field isolates of L. donovani [31] . In another study, western blot analysis was conducted and a 4-fold increase in the levels of TR protein detected in the resistant line vs. the susceptible one [40] . We exhibited a diminished expression level in both groups of patients except for three isolates. TR is one of the therapeutic targets for Leishmania in several studies although, it might not be universally accepted. Its expression in our samples may be affected by the drug and leading to decreased levels; but the increase in gene expression is inadequate Figure 6 Average of relative gene expression of five resistance markers in unresponsive isolates compared to responsive ones with respect to S175 and R439 reference isolates. A significant decrease in the expression of AQP1 and c-GCS was observed in unresponsive isolates compared to responsive ones. Values given are mean AE SD of three different experiments (**P < 0.01 and *P < .05).
AQP1 gene expression in improvement of disease alone, because other biochemical pathways probably play a role in the metabolic system of Leishmania, and can also in turn contribute to the disease [47] . Thiol-dependent reductase1 (TDR1) is a gene-encoding enzyme catalysing the reduction of SbV to active form Sb III using GSH as the reductant. The higher abundance of enzyme could explain greater susceptibility of amastigote forms to the drug [48] . Different results were obtained from TDR1 gene expression level of various isolates from non-significant [38, 49] to over-expression [50] . In the present survey, a high expression level of 3.55-fold was observed in responsive vs. unresponsive isolates, indicating that its down-regulation may be one of the agents responsible for the resistant phenotype in field isolates.
Different resistant Leishmania isolates may utilise various resistance mechanisms against a unique therapeutic agent. It should be noted that in addition to the leishmanial factors, the immune status of patients with leishmaniasis could affect drug efficacy [17] . All patients in this investigation were immunocompetent without known immunodeficiency diseases. However, the interplay between genetic parameters of host and parasite may have profound influences on drug efficacy that should be considered in further studies.
In conclusion, the inventory of leishmanicidal drugs is extremely small, and emergence of drug resistance is inevitably complicating the control of leishmaniasis. A better understanding of drug resistance mechanisms may be helpful for more rational application of drugs. Therefore, we employed real-time qPCR approach to detect five target genes (AQP1, MRPA, c-GCS, TDR1 and TR) responsible for the clinical resistance to antimonials in L. tropica isolates in the southeastern Iran. The AQP1 and c-GCS showed a strong positive correlation and also significant expression level between two groups, indicating their potential role to detect drug-unresponsive parasite. However, these genes alone are insufficient to pinpoint unresponsive isolates as they may be expressed in a non-identical manner under various conditions in different isolates. Identification of host genetic features and immune responses simultaneously with reliable molecular markers may be helpful to distinguish between SbV-resistant and SbV-sensitive L. tropica. Hence, combination therapy or the use of other drugs could be an alternative for treating the disease until an efficacious vaccine or superior drug becomes available. Figure 8 Correlation analyses between c-GCS (a), AQP1 (b) and MRPA gene expression (c) and lesion duration in responsive patients with ACL. c-GCS and AQP1 genes showed a negative linear correlation. Moreover, it showed no linear correlation between the MRPA gene expression and number of lesions (*P < .05 and **P < 0.01).
